6.16
price down icon8.61%   -0.58
after-market Handel nachbörslich: 6.10 -0.06 -0.97%
loading
Schlusskurs vom Vortag:
$6.74
Offen:
$6.59
24-Stunden-Volumen:
2.35M
Relative Volume:
1.76
Marktkapitalisierung:
$437.37M
Einnahmen:
$65,400
Nettoeinkommen (Verlust:
$-46.34M
KGV:
-6.6957
EPS:
-0.92
Netto-Cashflow:
$-38.74M
1W Leistung:
-42.80%
1M Leistung:
-40.54%
6M Leistung:
-23.76%
1J Leistung:
+45.28%
1-Tages-Spanne:
Value
$6.09
$6.64
1-Wochen-Bereich:
Value
$6.09
$9.25
52-Wochen-Spanne:
Value
$3.61
$13.85

CorMedix Inc Stock (CRMD) Company Profile

Name
Firmenname
CorMedix Inc
Name
Telefon
908-517-9500
Name
Adresse
400 Connell Drive, 5th Floor, Suite 5000, Berkeley Heights, NJ
Name
Mitarbeiter
14
Name
Twitter
Name
Nächster Verdiensttermin
2025-03-25
Name
Neueste SEC-Einreichungen
Name
CRMD's Discussions on Twitter

Vergleichen Sie CRMD mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
CRMD
CorMedix Inc
6.16 437.37M 65,400 -46.34M -38.74M -0.92
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.82 131.41B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
634.23 72.26B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
591.87 36.10B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
270.02 35.03B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
272.17 28.24B 3.81B -644.79M -669.77M -6.24

CorMedix Inc Stock (CRMD) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-03-07 Eingeleitet Leerink Partners Outperform
2025-01-13 Eingeleitet D. Boral Capital Buy
2024-08-26 Eingeleitet Rodman & Renshaw Buy
2023-08-10 Eingeleitet RBC Capital Mkts Outperform
2021-02-17 Eingeleitet Needham Buy
2020-09-29 Eingeleitet JMP Securities Mkt Outperform
2020-09-21 Eingeleitet Truist Buy
2019-12-18 Eingeleitet B. Riley FBR Buy
2019-03-26 Bestätigt H.C. Wainwright Buy
2018-12-06 Eingeleitet ROTH Capital Buy
2017-09-25 Bestätigt H.C. Wainwright Buy
2017-08-10 Bestätigt Rodman & Renshaw Buy
2017-05-05 Bestätigt Rodman & Renshaw Buy
2016-11-11 Bestätigt FBR & Co. Outperform
2016-03-17 Bestätigt FBR Capital Outperform
2016-03-03 Eingeleitet FBR Capital Outperform
2015-11-16 Bestätigt ROTH Capital Neutral
2015-10-29 Bestätigt ROTH Capital Neutral
2015-05-06 Herabstufung ROTH Capital Buy → Neutral
2014-12-08 Bestätigt ROTH Capital Buy
2011-10-03 Herabstufung Maxim Group Buy → Hold
Alle ansehen

CorMedix Inc Aktie (CRMD) Neueste Nachrichten

pulisher
Mar 29, 2025

CorMedix Inc. (NASDAQ:CRMD) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 29, 2025
pulisher
Mar 28, 2025

CorMedix Inc. Reports Record Q4 Earnings and Growth - TipRanks

Mar 28, 2025
pulisher
Mar 28, 2025

CorMedix: A Fair-Priced Biotech Company With A Bright Future - Seeking Alpha

Mar 28, 2025
pulisher
Mar 27, 2025

CORMEDIX ALERT: Bragar Eagel & Squire, P.C. is - GlobeNewswire

Mar 27, 2025
pulisher
Mar 27, 2025

CORMEDIX ALERT: Bragar Eagel & Squire, P.C. is Investigating CorMedix Inc. on Behalf of ... - Bluefield Daily Telegraph

Mar 27, 2025
pulisher
Mar 27, 2025

Institutions along with individual investors who hold considerable shares inCorMedix Inc. (NASDAQ:CRMD) come under pressure; lose 35% of holdings value - Yahoo Finance

Mar 27, 2025
pulisher
Mar 27, 2025

CorMedix Inc.'s (NASDAQ:CRMD) 35% loss last week hit both individual investors who own 56% as well as institutions - simplywall.st

Mar 27, 2025
pulisher
Mar 27, 2025

CorMedix targets $50M-$60M revenue for H1 2025 with DefenCath growth - MSN

Mar 27, 2025
pulisher
Mar 26, 2025

Lost Money on CorMedix Inc.(CRMD)? Contact Levi & Korsinsky Regarding an Ongoing Investigation - ACCESS Newswire

Mar 26, 2025
pulisher
Mar 26, 2025

Kirby McInerney LLP Announces Investigation Against CorMedix Inc. (CRMD) on Behalf of Investors - GlobeNewswire

Mar 26, 2025
pulisher
Mar 26, 2025

The Hidden Risks Behind CorMedix's First Profitable Quarter (NASDAQ:CRMD) - Seeking Alpha

Mar 26, 2025
pulisher
Mar 26, 2025

CorMedix Inc (NASDAQ:CRMD) Order Delay - FXDailyReport.com

Mar 26, 2025
pulisher
Mar 26, 2025

Long Term Trading Analysis for (CRMD) - Stock Traders Daily

Mar 26, 2025
pulisher
Mar 26, 2025

INVESTOR ALERT: Investigation of CorMedix Inc. (CRMD) Announced by Holzer & Holzer, LLC - GlobeNewswire

Mar 26, 2025
pulisher
Mar 26, 2025

Cormedix Inc (CRMD) Q4 2024 Earnings Call Highlights: A Profitable Quarter Amidst Strategic ... By GuruFocus - Investing.com Canada

Mar 26, 2025
pulisher
Mar 26, 2025

CorMedix Inc. Achieves Profitability with DefenCath Launch - TipRanks

Mar 26, 2025
pulisher
Mar 25, 2025

CorMedix: Q4 Earnings Snapshot - MySA

Mar 25, 2025
pulisher
Mar 25, 2025

Rodman & Renshaw reiterates CorMedix stock Buy rating, $20 target By Investing.com - Investing.com South Africa

Mar 25, 2025
pulisher
Mar 25, 2025

Rodman & Renshaw reiterates CorMedix stock Buy rating, $20 target - Investing.com

Mar 25, 2025
pulisher
Mar 25, 2025

CorMedix (CRMD) Q4 2024 Earnings Call Transcript - AOL.com

Mar 25, 2025
pulisher
Mar 25, 2025

CorMedix earnings beat by $0.05, revenue topped estimates - Investing.com Canada

Mar 25, 2025
pulisher
Mar 25, 2025

Needham Cuts CorMedix's Price Target to $12 from $18, Keeps Buy Rating - MarketScreener

Mar 25, 2025
pulisher
Mar 25, 2025

CorMedix Stock Loses Almost A Third Of Its Market Cap After Downbeat H1 Revenue Outlook – But Retail Shrugs It - Asianet Newsable

Mar 25, 2025
pulisher
Mar 25, 2025

Cormedix: Positive Outlook with Strategic Advancements and Strong Financial Performance - TipRanks

Mar 25, 2025
pulisher
Mar 25, 2025

CorMedix Inc. (CRMD) Takes a Hit: What’s Behind the 31% Plunge? - RagingBull

Mar 25, 2025
pulisher
Mar 25, 2025

Nasdaq Gains 50 Points; US New Home Sales Rise In February - Benzinga

Mar 25, 2025
pulisher
Mar 25, 2025

CorMedix Stock Loses Almost A Third Of Its Market Cap After Downbeat H1 Revenue Outlook – But Retail Shrugs It Off - MSN

Mar 25, 2025
pulisher
Mar 25, 2025

Earnings call transcript: CorMedix Q4 2024 reports first profit, stock plunges - Investing.com Australia

Mar 25, 2025
pulisher
Mar 25, 2025

CorMedix shares tumble after order delay By Investing.com - Investing.com Philippines

Mar 25, 2025
pulisher
Mar 25, 2025

CorMedix shares tumble after order delay - Investing.com

Mar 25, 2025
pulisher
Mar 25, 2025

Earnings call transcript: CorMedix Q4 2024 reports first profit, stock plunges By Investing.com - Investing.com South Africa

Mar 25, 2025
pulisher
Mar 25, 2025

CorMedix Dives on Results - Baystreet.ca

Mar 25, 2025
pulisher
Mar 25, 2025

CorMedix Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 25, 2025
pulisher
Mar 25, 2025

CorMedix Q4 Swings To Profit, Stock Down In Pre-market - Nasdaq

Mar 25, 2025
pulisher
Mar 25, 2025

CorMedix Inc. Provides Preliminary Earnings Guidance for the First Half of 2025 - Marketscreener.com

Mar 25, 2025
pulisher
Mar 25, 2025

CorMedix (CRMD) Q4 Earnings and Revenues Beat Estimates - Yahoo Finance

Mar 25, 2025
pulisher
Mar 25, 2025

CORMEDIX Earnings Results: $CRMD Reports Quarterly Earnings - Nasdaq

Mar 25, 2025
pulisher
Mar 25, 2025

CorMedix Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - The Manila Times

Mar 25, 2025
pulisher
Mar 25, 2025

CorMedix Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - Marketscreener.com

Mar 25, 2025
pulisher
Mar 25, 2025

CorMedix Hits Major Milestone: First-Ever Profitable Quarter Signals Strong Growth Ahead - Stock Titan

Mar 25, 2025
pulisher
Mar 24, 2025

CorMedix Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call - Benzinga

Mar 24, 2025
pulisher
Mar 23, 2025

CORMEDIX Earnings Preview: Recent $CRMD Insider Trading, Hedge Fund Activity, and More - Nasdaq

Mar 23, 2025
pulisher
Mar 21, 2025

CorMedix Inc expected to post earnings of 14 cents a shareEarnings Preview - TradingView

Mar 21, 2025
pulisher
Mar 19, 2025

CRMD INVESTOR NOTICE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages CorMedix Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important September 20 Deadline in Securities Class Action – CRMD - Business Wire

Mar 19, 2025
pulisher
Mar 18, 2025

CorMedix Inc. to Report Fourth Quarter and Full Year 2024 Financial Results and Provide a Corporate Update on March 25, 2025 - The Manila Times

Mar 18, 2025
pulisher
Mar 18, 2025

CorMedix Inc. to Announce Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025 - Nasdaq

Mar 18, 2025
pulisher
Mar 18, 2025

Cormedix Inc. To Report Fourth Quarter And Full Year 2024 Financial Results And Provide A Corporate Update On March 25, 2025 - MENAFN.COM

Mar 18, 2025
pulisher
Mar 16, 2025

(CRMD) Investment Report - news.stocktradersdaily.com

Mar 16, 2025
pulisher
Mar 14, 2025

Li Auto, Xponential Fitness And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Benzinga India

Mar 14, 2025

Finanzdaten der CorMedix Inc-Aktie (CRMD)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$70.69
price down icon 1.05%
$76.29
price down icon 2.18%
$31.13
price down icon 0.77%
$19.29
price down icon 5.07%
$91.06
price down icon 4.10%
biotechnology ONC
$272.17
price up icon 1.79%
Kapitalisierung:     |  Volumen (24h):